• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖和终末期肾病患者中KIDINS220基因多态性的发生率显著更高。

Significantly higher rates of KIDINS220 polymorphisms in patients with obesity and end-stage renal disease.

作者信息

Richards Jesse, Dorand Madisen Fae, Paszkowiak Maria, Ahmed Sana, McCorkle Courtney, Kathuria Pranay

机构信息

Department of Internal Medicine, University of Oklahoma School of Community Medicine, 4502 E. 41st Street, Tulsa, OK, 74135, USA.

College of Medicine, University of Oklahoma School of Community Medicine, 4502 E. 41st Street, Tulsa, OK, 74135, USA.

出版信息

Obes Pillars. 2024 Dec 5;13:100155. doi: 10.1016/j.obpill.2024.100155. eCollection 2025 Mar.

DOI:10.1016/j.obpill.2024.100155
PMID:39801599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11719405/
Abstract

BACKGROUND

Kinase D-interacting substrate of 220 kDa ("KIDINS220") is an integral plasma membrane protein essential to signaling throughout the body; abnormalities are linked to a variety of disorders, including obesity, but have never been directly linked to chronic- or end-stage renal disease.

METHODS

Retrospective chart review identified patients with severe obesity who presented for pre-kidney transplant weight management. 20 individuals met criteria for testing for genetic causes of obesity. A χ test of independence was utilized to compare genetic mutation rates in this cohort to all individuals tested nationally.

RESULTS

This case series presents a cohort of patients with severe obesity and end-stage renal disease who were subsequently found to have a significantly higher rate of KIDINS220 mutations (20 %, χ = 27.8,  < 0.0001) compared to the national positivity rate of all individuals tested for genetic causes of obesity.

CONCLUSIONS

Mutations within KIDINS220 may play a modulatory role in the progression of chronic kidney disease in patients with obesity, as evidenced by this small retrospective study. The relationship between KIDINS200, kidney disease, and obesity is complex and requires further study, but may represent a potential therapeutic target in the future.

摘要

背景

220 kDa的激酶D相互作用底物(“KIDINS220”)是一种完整的质膜蛋白,对全身信号传导至关重要;异常与多种疾病相关,包括肥胖症,但从未直接与慢性或终末期肾病相关联。

方法

通过回顾性病历审查确定了前来进行肾脏移植前体重管理的重度肥胖患者。20名个体符合肥胖症遗传病因检测标准。采用独立性χ检验将该队列中的基因突变率与全国所有接受检测的个体进行比较。

结果

本病例系列呈现了一组重度肥胖和终末期肾病患者,随后发现他们的KIDINS220突变率(20%,χ = 27.8,P < 0.0001)显著高于因肥胖症遗传病因接受检测的所有个体的全国阳性率。

结论

这项小型回顾性研究表明,KIDINS220内的突变可能在肥胖症患者慢性肾病进展中起调节作用。KIDINS200、肾病和肥胖症之间的关系复杂,需要进一步研究,但未来可能代表一个潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa67/11719405/fe7838973d0c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa67/11719405/4a487eed2584/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa67/11719405/fe7838973d0c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa67/11719405/4a487eed2584/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa67/11719405/fe7838973d0c/gr2.jpg

相似文献

1
Significantly higher rates of KIDINS220 polymorphisms in patients with obesity and end-stage renal disease.肥胖和终末期肾病患者中KIDINS220基因多态性的发生率显著更高。
Obes Pillars. 2024 Dec 5;13:100155. doi: 10.1016/j.obpill.2024.100155. eCollection 2025 Mar.
2
Prenatal delineation of a distinct lethal fetal syndrome caused by a homozygous truncating KIDINS220 variant.产前诊断一种由 KIDINS220 纯合截短变异引起的致死性胎儿综合征。
Am J Med Genet A. 2020 Dec;182(12):2867-2876. doi: 10.1002/ajmg.a.61858. Epub 2020 Sep 10.
3
Kinase D-interacting Substrate of 220 kDa Is Overexpressed in Gastric Cancer and Associated With Local Invasion.220 kDa 蛋白激酶 D 相互作用底物在胃癌中过表达,并与局部浸润相关。
Cancer Genomics Proteomics. 2023 Dec;20(6suppl):735-743. doi: 10.21873/cgp.20420.
4
Novel autosomal recessive SINO syndrome-associated variants provide insight into the genotype-phenotype correlation.新型常染色体隐性遗传性SINO综合征相关变异为基因型-表型相关性研究提供了线索。
Heliyon. 2024 Sep 2;10(17):e37355. doi: 10.1016/j.heliyon.2024.e37355. eCollection 2024 Sep 15.
5
Pure Hereditary Spastic Paraplegia in a Patient With a Novel Heterozygous KIDINS220 Gene Mutation.一名携带新型杂合KIDINS220基因突变患者的纯合性遗传性痉挛性截瘫
Cureus. 2024 Jul 7;16(7):e64023. doi: 10.7759/cureus.64023. eCollection 2024 Jul.
6
Identification and cloning of Kidins220, a novel neuronal substrate of protein kinase D.蛋白激酶D的新型神经元底物Kidins220的鉴定与克隆
J Biol Chem. 2000 Dec 22;275(51):40048-56. doi: 10.1074/jbc.M005261200.
7
Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradation.Kidins220 缺乏通过 SNX27-网格蛋白依赖的 AQP4 降解引起脑室扩大。
Mol Psychiatry. 2021 Nov;26(11):6411-6426. doi: 10.1038/s41380-021-01127-9. Epub 2021 May 17.
8
Kidins220-deficient hydrocephalus mice exhibit altered glial phenotypes and AQP4 differential regulation in the retina and optic nerve, with preserved retinal ganglion cell survival.缺乏Kidins220的脑积水小鼠在视网膜和视神经中表现出神经胶质细胞表型改变和水通道蛋白4(AQP4)的差异调节,同时视网膜神经节细胞的存活得以保留。
Fluids Barriers CNS. 2025 Feb 12;22(1):16. doi: 10.1186/s12987-025-00626-z.
9
Differential regulation of Kidins220 isoforms in Huntington's disease.亨廷顿病中 Kidins220 异构体的差异调节。
Brain Pathol. 2020 Jan;30(1):120-136. doi: 10.1111/bpa.12761. Epub 2019 Jul 16.
10
Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.Kidins220 在人类阿尔茨海默病和相关模型中与 tau 聚集:GSK3β/PP1 失衡对其钙蛋白酶处理的调节。
Hum Mol Genet. 2013 Feb 1;22(3):466-82. doi: 10.1093/hmg/dds446. Epub 2012 Oct 31.

本文引用的文献

1
Proneurotensin/Neuromedin N and Risk of Incident CKD and Other Kidney Outcomes in Community-Living Individuals: The REGARDS Study.前神经降压素/神经介素N与社区居住个体发生慢性肾脏病及其他肾脏结局的风险:REGARDS研究
Kidney Med. 2024 Apr 24;6(6):100831. doi: 10.1016/j.xkme.2024.100831. eCollection 2024 Jun.
2
Obesity and the kidney: mechanistic links and therapeutic advances.肥胖与肾脏:机制关联与治疗进展。
Nat Rev Endocrinol. 2024 Jun;20(6):321-335. doi: 10.1038/s41574-024-00951-7. Epub 2024 Feb 13.
3
Kidins220 sets the threshold for survival of neural stem cells and progenitors to sustain adult neurogenesis.
Kidins220 为神经干细胞和祖细胞的存活设定了阈值,以维持成年神经发生。
Cell Death Dis. 2023 Aug 4;14(8):500. doi: 10.1038/s41419-023-05995-7.
4
Obesity and chronic kidney disease: A current review.肥胖与慢性肾脏病:当前综述
Obes Sci Pract. 2022 Jul 19;9(2):61-74. doi: 10.1002/osp4.629. eCollection 2023 Apr.
5
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.促黑素细胞激素 4 受体激动剂赛麦兰肽治疗 Bardet-Biedl 综合征和 Alström 综合征患者的疗效和安全性:一项多中心、随机、双盲、安慰剂对照、有开放标签期的 3 期临床试验。
Lancet Diabetes Endocrinol. 2022 Dec;10(12):859-868. doi: 10.1016/S2213-8587(22)00277-7. Epub 2022 Nov 7.
6
Genetics of Obesity in Humans: A Clinical Review.人类肥胖的遗传学:临床综述。
Int J Mol Sci. 2022 Sep 20;23(19):11005. doi: 10.3390/ijms231911005.
7
Recipient obesity as a risk factor in kidney transplantation.受者肥胖作为肾移植的一个危险因素。
BMC Nephrol. 2022 Jan 18;23(1):37. doi: 10.1186/s12882-022-02668-z.
8
Obesity-Related Glomerulopathy: From Mechanism to Therapeutic Target.肥胖相关性肾小球病:从发病机制到治疗靶点
Diabetes Metab Syndr Obes. 2021 Oct 28;14:4371-4380. doi: 10.2147/DMSO.S334199. eCollection 2021.
9
Obesity and bariatric surgery in kidney transplantation: A clinical review.肾移植中的肥胖与减肥手术:临床综述
World J Diabetes. 2021 Sep 15;12(9):1563-1575. doi: 10.4239/wjd.v12.i9.1563.
10
SINO Syndrome Causative KIDINS220/ARMS Gene Regulates Adipocyte Differentiation.SINO综合征致病基因KIDINS220/ARMS调控脂肪细胞分化。
Front Cell Dev Biol. 2021 Mar 4;9:619475. doi: 10.3389/fcell.2021.619475. eCollection 2021.